 Oral ofloxacin treatment acute bacterial pneumonia use nontraditional protocol experimental therapy usual care multicenter clinical trial PURPOSE multicenter study oral regimen usual care patients acute bacterial pneumonia PATIENTS METHODS forty-seven patients patients clinical picture consistent pneumonia clinical symptoms respiratory tract infection chest pain cough production purulent sputum roentgenographic infiltrate compatible acute infection Gram stain purulent sputum appropriate bronchopulmonary specimen gram-negative organisms staphylococci pneumococci patients hospitalization design parallel-group open-label study randomization blocks Ofloxacin new fluoroquinolone antimicrobial agent nasogastric tube mg hours individual investigator selection therapy RESULTS thirty-three patients evaluable exclusions deviation protocol early death due unrelated causes incorrect diagnosis early adverse drug reactions patients ofloxacin control patients favorable clinical microbiologic responses significant differences groups terms demographics therapeutic outcome duration therapy side effects overall rates similar groups CONCLUSIONS oral regimen case parenteral therapy patients pneumonia costs risks patient